Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > How Is Waters Corporation’s Stock Performance Compared to Other Healthcare Stocks?
Economy

How Is Waters Corporation’s Stock Performance Compared to Other Healthcare Stocks?

Last updated: June 20, 2025 3:07 pm
Share
How Is Waters Corporation’s Stock Performance Compared to Other Healthcare Stocks?
SHARE

Waters Corporation (WAT) is a prominent player in the global analytical instruments and laboratory solutions market, boasting a market cap of $20.2 billion. The company operates through its Waters and TA Divisions, offering high-performance liquid chromatography, mass spectrometry, and thermal analysis systems to a wide range of customers in the pharmaceutical, life science, industrial, and governmental sectors.

As a large-cap stock with a market value exceeding $10 billion, Waters Corporation has established itself as a leader in the industry. Its innovative products cater to research, development, and quality assurance applications for customers across Asia, the Americas, and Europe.

Despite its strong position in the market, Waters Corporation’s stock has experienced a decline in recent months. Shares have fallen by 19.9% from their 52-week high of $423.56, underperforming the Health Care Select Sector SPDR Fund (XLV), which saw a 9.3% dip during the same period. In the longer term, WAT stock is down 8.5% year-to-date, although it has returned 15.3% over the past 52 weeks, outperforming XLV’s 8.7% decline during the same period.

The stock has been trading below its 200-day moving average since April, indicating a bearish trend. Despite reporting better-than-expected Q1 2025 adjusted EPS of $2.25 and revenue of $661.7 million, investor concerns over macroeconomic uncertainties and tariff impacts led to a 2.7% drop in WAT shares on May 6. However, the company raised its full-year adjusted EPS guidance to $12.75 – $13.05 and constant currency sales growth to 5% – 7%.

In comparison to its rival, Thermo Fisher Scientific Inc. (TMO), Waters Corporation has outperformed, with TMO stock falling 31% over the past 52 weeks and 24.5% year-to-date. Despite its strong performance, analysts remain cautiously optimistic about the stock’s prospects. With a consensus rating of “Moderate Buy” from 18 analysts, the stock is currently trading below the mean price target of $393.

See also  Ramaswamy-backed Strive to buy Semler in $1.3 billion deal all stock deal, boosting Bitcoin holdings

In conclusion, Waters Corporation continues to be a key player in the analytical instruments and laboratory solutions market, with a strong presence globally. While the stock has faced some challenges in recent months, the company’s solid financial performance and innovative product offerings position it well for future growth. Investors should keep a close eye on developments in the industry and macroeconomic conditions to make informed decisions about investing in WAT stock.

TAGGED:ComparedCorporationsHealthcarePerformanceStockstockswaters
Share This Article
Twitter Email Copy Link Print
Previous Article New York’s mayoral race could decide the city’s climate future New York’s mayoral race could decide the city’s climate future
Next Article The Resilient American Dream – Econlib The Resilient American Dream – Econlib
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

The Kid LAROI vs Vinnie Hacker Who’d You Rather?! (Music Festiva Studs Edition)

The Kid Laroi vs Vinnie Hacker Who'd You Rather?! (Music Festival Studs Edition) Published April…

April 18, 2025

Federal judge limits DOGE access to Treasury Dept payment records 

Affiliate of DOGE Linked to Offensive Social Media Posts Resigns Amid Lawsuit A federal judge…

February 6, 2025

Trump greets hundreds of trick-or-treaters at White House Halloween

President Trump and first lady Melania participated in a Halloween celebration at the White House,…

October 30, 2025

The Pete Rose situation explained: What a Trump pardon, commissioner discussions may mean

Major League Baseball commissioner Rob Manfred is currently reviewing a request for Pete Rose to…

March 5, 2025

Antidepressants in pregnancy: Doctors decry ‘misinformation’ after FDA panel meets : Shots

Doctors are criticizing a recent expert panel organized by the U.S. Food and Drug Administration…

August 1, 2025

You Might Also Like

Market analysts react to Trump-Xi meet
Economy

Market analysts react to Trump-Xi meet

October 31, 2025
29 truck carrier files Chapter 11
Economy

29 truck carrier files Chapter 11

October 31, 2025
Trust Government Statistics, Not Government
Economy

Trust Government Statistics, Not Government

October 31, 2025
Jefferies Raises BP Price Target to 420 GBp, Maintains Hold Rating
Economy

Jefferies Raises BP Price Target to 420 GBp, Maintains Hold Rating

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?